Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

PIPERACILLIN SODIUM

FDA · NDA · 2025-04-03

AgencyFDA
Submission typeNDA
Action date2025-04-03
BrandPIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
SponsorB BRAUN MEDICAL
RouteINTRAVENOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:29:50.094Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:PIPERACILLIN SODIUM:2025-04-03

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

PIPERACILLIN SODIUM — approval | AEaH